Pediatrics · Durham, NC
NPI
1114001021
Since 2006
Specialty
Pediatrics
Code 208000000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
2100 Erwin Rd
Durham, NC, 27710
Phone (919) 684-8111
Groups this clinician bills Medicare through
Medicare paid, 2024
$2,211
35 services
Medicare patients, 2024
15
Average age 61
Drug cost, 2024
$8.6M
110 prescriptions
Company payments, 2025
$320K
From 10 companies
Medicare prescription drug claims, 2024
In 2024, the drug Priya Kishnani prescribed most often to Medicare patients was Strensiq (Asfotase Alfa), with 55 prescriptions and refills. In total Priya Kishnani wrote 110 Medicare prescriptions that cost $8.6M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-06-06.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Strensiq Asfotase Alfa | 55 | 55 | Under 11 | $5.9M |
| Cerdelga Eliglustat Tartrate | 25 | 25 | Under 11 | $760K |
| Nexviazyme Avalglucosidase Alfa-Ngpt | 23 | 23 | Under 11 | $1.9M |
Brand drugs: 107 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Priya Kishnani $320K ($320K in general payments such as food, travel and fees) from 10 companies. The largest payer was Alnylam Pharmaceuticals Inc. with $221K.
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. ALNY | 7 | $221K |
| Amicus Therapeutics, Inc. FOLD | 14 | $34K |
| Genzyme Corporation SNY | 13 | $29K |
| Chiesi USA, Inc. | 2 | $11K |
| Alexion Pharmaceuticals, Inc. AZN | 3 | $7,990 |
| Sanofi US Services Inc. SNY | 1 | $6,040 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 3 | $5,437 |
| Regeneron Pharmaceuticals, Inc. REGN | 6 | $3,800 |
| ModernaTX, Inc. MRNA | 1 | $2,320 |
| Eli Lilly and Company LLY | 1 | $118 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.